Switching to IDegLira is effective regardless of pre-trial insulin dose in patients with T2D uncontrolled on IGlar U100

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility